GHK-CU 10 mg by Dragon Pharma

Dragon Pharma Original Formula

GHK-Cu

Copper Tripeptide-110 mg vial
Class Copper Tripeptide
Sequence Gly-His-Lys + Cu²⁺
Active at 1 nanomolar concentration
Suppression None (HPG)
Reconstitution Bacteriostatic Water
Form Subcutaneous Vial
Availability: Out of stock
Wishlist

GHK-Cu — Copper Tripeptide-1 by Dragon Pharma

GHK-Cu is Dragon Pharma's formulation of Copper Tripeptide-1 (Glycyl-L-Histidyl-L-Lysine complexed with copper) at 10mg per vial — a naturally occurring tripeptide found in human plasma that becomes one of the most studied and potent peptides for skin regeneration, wound healing and systemic gene regulation. Its biological activity at concentrations as low as 1 nanomolar makes it among the most potent naturally occurring signalling peptides by molar concentration.

Also searched as: GHK-Cu copper peptide, Glycyl-L-Histidyl-L-Lysine copper, GHK-Cu 10mg, copper tripeptide-1 Dragon Pharma.

What GHK-Cu Is — Origin and Natural Role

GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Cu²⁺) is a tripeptide naturally present in human plasma, saliva and urine. Its plasma concentration declines significantly with age:

  • At age 20: plasma GHK-Cu approximately 200 nanograms/ml
  • At age 60: plasma GHK-Cu approximately 80 nanograms/ml — a 60% decline
  • This age-related decline correlates temporally with reduced skin collagen production, impaired wound healing and reduced antioxidant capacity — supporting the hypothesis that GHK-Cu decline is functionally linked to aspects of biological aging

GHK-Cu was first isolated by Loren Pickart in 1973 from human plasma albumin, and subsequent decades of research have established it as one of the most biologically active naturally occurring peptides, with influence extending well beyond the skin to systemic gene regulation.

The Nanomolar Potency — Why Concentration Matters

GHK-Cu's activity at 1 nanomolar concentration is a key information gap in competitor content:

  • 1 nanomolar = 0.000001 mg/ml — an extraordinarily low concentration for meaningful biological activity
  • For reference: most amino acid supplements are dosed in gram quantities; most peptide hormones are effective at microgram concentrations; GHK-Cu is biologically active at nanomolar concentrations — three orders of magnitude lower than microgram-level compounds
  • This extreme potency means that even the small amounts of GHK-Cu delivered by the 10mg vial are far above the threshold for biological activity in tissue
  • It also explains why GHK-Cu is included at useful concentrations in multi-peptide blends like the Klow Blend — a small absolute mass can produce meaningful effects

The Gene Regulation Discovery — Beyond Skin

The most significant and least-known aspect of GHK-Cu — a genuine information gap across virtually all competitor content:

  • A 2012 analysis by Loren Pickart and colleagues, using gene chip microarray technology, identified that GHK-Cu modulates the expression of over 4,000 human genes — approximately 31% of all expressed human genes
  • The genes affected include pathways governing inflammation, tissue remodelling, DNA repair, antioxidant defence, angiogenesis and nervous system function
  • Key findings: GHK-Cu upregulates anti-inflammatory and tissue repair genes while downregulating genes associated with tumour progression, inflammation and fibrosis
  • This systemic gene regulatory activity reframes GHK-Cu from a "skin peptide" into a broader biological repair and rejuvenation signal — explaining its effects beyond topical skin applications

Documented Mechanisms and Pathways

Mechanism Pathway Effect
Collagen synthesis TGF-β upregulation in fibroblasts Increased collagen I and III production; improved skin structure and wound healing
Angiogenesis VEGF upregulation New blood vessel formation supporting tissue repair and nutrient delivery
Antioxidant defence Superoxide dismutase (SOD) upregulation Reduced oxidative stress in skin and other tissues
Hair follicle Dermal papilla cell activation Enlarged hair follicles; extended anagen phase; documented hair regrowth in animal and some human studies
Wound healing Multiple growth factor signalling Accelerated wound contraction and epithelialisation
Gene regulation Epigenetic modulation of 4,000+ genes Systemic shift toward repair and anti-inflammatory gene expression

Effects and Benefits

  • Collagen and elastin production — via TGF-β activation in fibroblasts; measurable improvements in skin thickness and elasticity documented in human studies
  • Wound healing acceleration — one of the most clinically established applications; used in wound care products
  • Hair follicle enlargement and anagen phase extension — documented in multiple studies; complementary to Minoxidil's KATP channel mechanism through a different pathway
  • Antioxidant upregulation via SOD — reduced cellular oxidative stress
  • Systemic gene regulation affecting repair, anti-inflammatory and rejuvenation pathways
  • No suppression of natural testosterone — no PCT required

Dosage and Administration

Protocol Dose Frequency Notes
Skin and anti-aging 1–2 mg/day Daily or every other day Subcutaneous, site of concern or general
Wound/injury focused 2–3 mg/day Daily near site Localised subcutaneous or near wound

At 10mg per vial and 1mg/day, a single vial provides 10 days of dosing. Given its nanomolar biological activity threshold, doses of 1-2mg/day provide concentrations substantially above the threshold for meaningful tissue response. Reconstitute with bacteriostatic water; store refrigerated at 2-8°C after reconstitution for up to 28-30 days. For larger protocols requiring 50mg total, Dragon Pharma also offers the GHK-Cu 50mg vial.

GHK-Cu vs Other Skin and Anti-Aging Peptides

Compound Primary Mechanism Unique Contribution
GHK-Cu TGF-β collagen; SOD antioxidant; 4000+ gene regulation Most broadly gene-regulatory skin/repair peptide; active at nanomolar concentration
Epitalon Telomerase activation; pineal gland support Cellular aging mechanism — telomere length; pineal/melatonin restoration
BPC-157 GH receptor upregulation; VEGF angiogenesis Localised tissue repair — tendons, gut; most potent for specific injury sites
Klow Blend 4-pathway: BPC+TB500+KPV+GHK-Cu Combines GHK-Cu's collagen with localised, systemic and immune pathways simultaneously

Reconstitution and Storage

Reconstitute with bacteriostatic water — add slowly along the vial wall and swirl gently. Store reconstituted vial refrigerated at 2-8°C for up to 28-30 days. Never freeze.

"GHK-Cu is one of the most potent naturally occurring signalling peptides in the Dragon Pharma range by molar concentration — active at 1 nanomolar, and documented to modulate over 4,000 human genes toward repair, anti-inflammatory and rejuvenation expression patterns."

Stacking and Related Compounds

  • Epitalon — telomere and pineal support alongside GHK-Cu's collagen and gene regulation for comprehensive anti-aging coverage
  • BPC-157 — localised tissue repair alongside GHK-Cu's broader collagen and skin regeneration
  • Minoxidil — for hair loss: complementary mechanisms (GHK-Cu's follicle enlargement via dermal papilla + Minoxidil's KATP channel anagen extension)
Please log in to write review.

GHK-Cu stands for Glycyl-L-Histidyl-L-Lysine complexed with copper (Cu²⁺). It is a naturally occurring tripeptide found in human plasma, saliva and urine, first isolated by Loren Pickart in 1973. Its plasma concentration declines approximately 60% between age 20 and 60, correlating with age-related declines in skin collagen, wound healing capacity and antioxidant defence.

1 nanomolar (0.000001 mg/ml) is the concentration threshold at which GHK-Cu produces documented biological effects — specifically collagen synthesis stimulation in fibroblasts and antioxidant upregulation. This is three orders of magnitude lower than typical microgram-level peptide thresholds, making GHK-Cu among the most potent naturally occurring signalling peptides by molar concentration.

A 2012 gene chip microarray analysis by Loren Pickart and colleagues identified that GHK-Cu influences expression of approximately 4,000 human genes — roughly 31% of all expressed human genes. The affected pathways include collagen synthesis, inflammation modulation, DNA repair, antioxidant defence and angiogenesis. GHK-Cu generally upregulates repair and anti-inflammatory genes while downregulating pro-inflammatory and pro-fibrotic gene expression.

GHK-Cu has documented effects on hair follicles — specifically enlarging dermal papilla cells and extending the anagen (active growth) phase. This operates through a different mechanism than Minoxidil's KATP channel opening, making them complementary rather than redundant when used together.

Both contain the same active compound at the same purity — the difference is total vial content. The 10mg vial provides approximately 10 days at 1mg/day or 5 days at 2mg/day. The 50mg vial provides significantly longer supply for extended protocols or higher daily doses, reducing the frequency of reconstitution and vial management.

No — GHK-Cu has no interaction with androgen receptors, estrogen receptors, or the HPG axis. It does not affect testosterone, LH, FSH or any reproductive hormones. It can be used during AAS cycles, during PCT, or independently without any hormonal consideration.